These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Oestrogen content of oral contraceptives and thromboembolism. McQueen EG N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982 [No Abstract] [Full Text] [Related]
17. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies. Beaumont V; Lemort N; Beaumont JL Artery; 1983; 11(5):331-44. PubMed ID: 6661039 [TBL] [Abstract][Full Text] [Related]
19. Observations with a combined oral contraceptive (Rigevidon) containing minimum oestrogen dose. Karsay K Ther Hung; 1980; 28(1):17-20. PubMed ID: 7281074 [TBL] [Abstract][Full Text] [Related]
20. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol. Lippman JS; Shangold GA Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456 [No Abstract] [Full Text] [Related] [Next] [New Search]